Clinical Trial Update: Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating protein C concentrate for severe congenital protein C deficiency with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Protein Deficiency

Drugs mentioned

• Protein C concentrate

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Protein C Deficiency | Phase 2, Phase 3 | Status: COMPLETED